Clinical Research Awards

Funding Agency:
Cystic Fibrosis Foundation

The intent of the Clinical Research Award program is to provide support for investigator-initiated clinical research projects that have the potential to make an important contribution to the Cystic Fibrosis Foundation's mission. Research projects may address diagnosis, treatment, management of disease or symptom, or the pathophysiology of cystic fibrosis, using clinical, (observational/interventional), translational, or epidemiologic study approaches.

Applicants must demonstrate access to a sufficient number of CF patients and to appropriate controls.

Up to $150,000 per year (plus 12 percent indirect costs) for a maximum of three years may be requested for single-center clinical research awards.

For multi-center clinical research, the potential award is up to $350,000 per year (plus 12 percent for indirect costs) for a maximum of three years.

 

Fall 2022

  • Letter of Intent: March 28, 2022
  • Full application: August 8, 2022

Spring 2023

  • Letter of Intent: September 16, 2022
  • Full application: February 2, 2023

Fall 2023

  • Letter of Intent: March 23, 2023
  • Full application: August 8, 2023

Agency Website

Areas of Interest

The CF Foundation seeks applications for the Clinical Research Award from all areas of clinical research that will have an impact on the lives of people with CF. However, the following research areas are of particular interest to the CF Foundation as they will address critical needs of people with CF:

  • Studies that investigate CF disease complications (lung, gastrointestinal (GI) tract, liver, pancreas, reproduction, mental health, endocrine, etc.)
  • Strategies to improve care and quality of life of people with CF
  • Assessment and validation of biomarkers, clinical trial tools, outcome measures, and efficacy endpoints
  • Translational or clinical studies in lung transplant1 research
  • Characterization of CF disease manifestations and management in the era of highly effective modulator therapy
  • Novel interventions that improve CF patient care and outcomes
  • Studies designed to translate laboratory findings of disease pathogenesis/treatment to clinical evaluation
  • Studies that identify and characterize racial, ethnic, and/or societal contributors to CF disease expression and management

Eligibility Requirements

Applicants must be independent investigators. Fellows may submit applications; however, funding will be considered only if they will hold a faculty-level appointment at the time of the award. Industry-sponsored research projects are not eligible for this award.

Amount Description

*NEW* Supplemental Funding to Address High Priority Areas  
Remote Collection Supplement: 
Applicants may request an additional $50,000 (plus 12% indirect costs) over the entire project period to include an additional aim that leverages the proposed main research study aims that address important gaps in knowledge and improve our understanding of the utility of remote collection of either specimens, endpoints, and/or clinical data to address these gaps in knowledge. This supplement is not intended to support Quality Improvement research in sample collection or patient use of daily therapies.  
  
Health Equity Supplement: Applicants may request an additional $50,000 (plus 12% indirect costs) over the entire project period to either advance our knowledge of health disparities in cystic fibrosis or enhance the diversity, equity, and inclusion in the biomedical workforce. 

Funding Type

Award

Eligibility

Faculty
Junior Faculty

Category

Medical
Medical - Clinical Science

External Deadline

September 16, 2022